These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds. Fischer A; Sellner M; Neranjan S; Smieško M; Lill MA Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455534 [TBL] [Abstract][Full Text] [Related]
48. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Boopathi S; Poma AB; Kolandaivel P J Biomol Struct Dyn; 2021 Jun; 39(9):3409-3418. PubMed ID: 32306836 [TBL] [Abstract][Full Text] [Related]
49. Repurposing approved drugs as inhibitors of SARS-CoV-2 S-protein from molecular modeling and virtual screening. de Oliveira OV; Rocha GB; Paluch AS; Costa LT J Biomol Struct Dyn; 2021 Jul; 39(11):3924-3933. PubMed ID: 32448085 [TBL] [Abstract][Full Text] [Related]
50. Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2. Kumar A; Loharch S; Kumar S; Ringe RP; Parkesh R Comput Struct Biotechnol J; 2021; 19():424-438. PubMed ID: 33391634 [TBL] [Abstract][Full Text] [Related]
51. Mutational analysis in international isolates and drug repurposing against SARS-CoV-2 spike protein: molecular docking and simulation approach. Pulakuntla S; Lokhande KB; Padmavathi P; Pal M; Swamy KV; Sadasivam J; Singh SA; Aramgam SL; Reddy VD Virusdisease; 2021 Dec; 32(4):690-702. PubMed ID: 34307771 [TBL] [Abstract][Full Text] [Related]
52. Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Li Z; Li X; Huang YY; Wu Y; Liu R; Zhou L; Lin Y; Wu D; Zhang L; Liu H; Xu X; Yu K; Zhang Y; Cui J; Zhan CG; Wang X; Luo HB Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27381-27387. PubMed ID: 33051297 [TBL] [Abstract][Full Text] [Related]
53. TAT-peptide conjugated repurposing drug against SARS-CoV-2 main protease (3CLpro): Potential therapeutic intervention to combat COVID-19. Ansari MA; Jamal QMS; Rehman S; Almatroudi A; Alzohairy MA; Alomary MN; Tripathi T; Alharbi AH; Adil SF; Khan M; Shaheer Malik M Arab J Chem; 2020 Nov; 13(11):8069-8079. PubMed ID: 34909057 [TBL] [Abstract][Full Text] [Related]
54. Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CL Koulgi S; Jani V; Uppuladinne M; Sonavane U; Nath AK; Darbari H; Joshi R J Biomol Struct Dyn; 2021 Sep; 39(15):5735-5755. PubMed ID: 32679006 [TBL] [Abstract][Full Text] [Related]
55. Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors. Hamed M; El-Hasab M; Mansour FR Virusdisease; 2021 Jun; 32(2):279-285. PubMed ID: 33948452 [TBL] [Abstract][Full Text] [Related]
56. Identification of FDA-approved drugs with triple targeting mode of action for the treatment of monkeypox: a high throughput virtual screening study. Srivastava V; Naik B; Godara P; Das D; Mattaparthi VSK; Prusty D Mol Divers; 2024 Jun; 28(3):1093-1107. PubMed ID: 37079243 [TBL] [Abstract][Full Text] [Related]
57. Modern drug discovery applications for the identification of novel candidates for COVID-19 infections. Rani I; Kalsi A; Kaur G; Sharma P; Gupta S; Gautam RK; Chopra H; Bibi S; Ahmad SU; Singh I; Dhawan M; Emran TB Ann Med Surg (Lond); 2022 Aug; 80():104125. PubMed ID: 35845863 [TBL] [Abstract][Full Text] [Related]
58. FDA Warns Coronavirus Outbreak May Disrupt Supply of Critical Medical Products. Stephenson J JAMA Health Forum; 2020 Feb; 1(2):e200222. PubMed ID: 36218644 [No Abstract] [Full Text] [Related]
59. High-Throughput Screening for Inhibitors of the SARS-CoV-2 Protease Using a FRET-Biosensor. Brown AS; Ackerley DF; Calcott MJ Molecules; 2020 Oct; 25(20):. PubMed ID: 33066278 [TBL] [Abstract][Full Text] [Related]
60. Structural analysis, virtual screening and molecular simulation to identify potential inhibitors targeting 2'-O-ribose methyltransferase of SARS-CoV-2 coronavirus. Jiang Y; Liu L; Manning M; Bonahoom M; Lotvola A; Yang Z; Yang ZQ J Biomol Struct Dyn; 2022 Feb; 40(3):1331-1346. PubMed ID: 33016237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]